Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 2003;11(3):175–179. doi: 10.1080/10647440300025518

Parvovirus B-19 Infection During Pregnancy

Anthony Al-Khan 1, Andrew Caligiuri 1, Joseph Apuzzio 1,✉
PMCID: PMC1852281  PMID: 15022880

Abstract

The development of an acute parvovirus B-19 infection during pregnancy can cause pregnancy complications ranging from early pregnancy loss to nonimmune hydrops. There is no treatment, but preventive measures can be used to decrease perinatal mortality. The diagnosis is made on the basis of clinical suspicion and serology. If the fetus exhibits hydrops in the latter part of pregnancy, the main treatment options include either correcting the associated anemia with intrauterine blood transfusion or birth with extrauterine management. Although the serious problems associated with this virus during pregnancy are uncommon, they can be fatal. In view of this, a pregnant woman who is antibody negative should try to avoid contact with large groups of young children in order to decrease contact with potential vectors.

Full Text

The Full Text of this article is available as a PDF (287.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler S. P., Manganello A. M., Koch W. C., Hempfling S. H., Best A. M. Risk of human parvovirus B19 infections among school and hospital employees during endemic periods. J Infect Dis. 1993 Aug;168(2):361–368. doi: 10.1093/infdis/168.2.361. [DOI] [PubMed] [Google Scholar]
  2. Ager E. A., Chin T. D., Poland J. D. Epidemic erythema infectiosum. N Engl J Med. 1966 Dec 15;275(24):1326–1331. doi: 10.1056/NEJM196612152752402. [DOI] [PubMed] [Google Scholar]
  3. Anderson M. J., Jones S. E., Fisher-Hoch S. P., Lewis E., Hall S. M., Bartlett C. L., Cohen B. J., Mortimer P. P., Pereira M. S. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet. 1983 Jun 18;1(8338):1378–1378. doi: 10.1016/s0140-6736(83)92152-9. [DOI] [PubMed] [Google Scholar]
  4. Bahado-Singh R. O., Oz A. U., Hsu C., Kovanci E., Deren O., Onderoglu L., Mari G. Middle cerebral artery Doppler velocimetric deceleration angle as a predictor of fetal anemia in Rh-alloimmunized fetuses without hydrops. Am J Obstet Gynecol. 2000 Sep;183(3):746–751. doi: 10.1067/mob.2000.106818. [DOI] [PubMed] [Google Scholar]
  5. Brown K. E., Green S. W., Antunez de Mayolo J., Bellanti J. A., Smith S. D., Smith T. J., Young N. S. Congenital anaemia after transplacental B19 parvovirus infection. Lancet. 1994 Apr 9;343(8902):895–896. doi: 10.1016/s0140-6736(94)90011-6. [DOI] [PubMed] [Google Scholar]
  6. Brown T., Anand A., Ritchie L. D., Clewley J. P., Reid T. M. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet. 1984 Nov 3;2(8410):1033–1034. doi: 10.1016/s0140-6736(84)91126-7. [DOI] [PubMed] [Google Scholar]
  7. Clewley J. P. Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens. J Clin Microbiol. 1989 Dec;27(12):2647–2651. doi: 10.1128/jcm.27.12.2647-2651.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cosmi Erich, Mari Giancarlo, Delle Chiaie Loredana, Detti Laura, Akiyama Masashi, Murphy June, Stefos Theodor, Ferguson James E., 2nd, Hunter David, Hsu Chaur-Dong. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection. Am J Obstet Gynecol. 2002 Nov;187(5):1290–1293. doi: 10.1067/mob.2002.128024. [DOI] [PubMed] [Google Scholar]
  9. Cossart Y. E., Field A. M., Cant B., Widdows D. Parvovirus-like particles in human sera. Lancet. 1975 Jan 11;1(7898):72–73. doi: 10.1016/s0140-6736(75)91074-0. [DOI] [PubMed] [Google Scholar]
  10. Eis-Hübinger A. M., Dieck D., Schild R., Hansmann M., Schneweis K. E. Parvovirus B19 infection in pregnancy. Intervirology. 1998;41(4-5):178–184. doi: 10.1159/000024933. [DOI] [PubMed] [Google Scholar]
  11. Fairley C. K., Smoleniec J. S., Caul O. E., Miller E. Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection. Lancet. 1995 Nov 18;346(8986):1335–1337. doi: 10.1016/s0140-6736(95)92346-2. [DOI] [PubMed] [Google Scholar]
  12. Humphrey W., Magoon M., O'Shaughnessy R. Severe nonimmune hydrops secondary to parvovirus B-19 infection: Spontaneous reversal in utero and survival of a term infant. Obstet Gynecol. 1991 Nov;78(5 Pt 2):900–902. [PubMed] [Google Scholar]
  13. Joseph P. R. Fifth disease: the frequency of joint involvement in adults. N Y State J Med. 1986 Nov;86(11):560–563. [PubMed] [Google Scholar]
  14. Karetnyi Y. V., Beck P. R., Markin R. S., Langnas A. N., Naides S. J. Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol. 1999;144(9):1713–1724. doi: 10.1007/s007050050699. [DOI] [PubMed] [Google Scholar]
  15. Klouda P. T., Corbin S. A., Bradley B. A., Cohen B. J., Woolf A. D. HLA and acute arthritis following human parvovirus infection. Tissue Antigens. 1986 Nov;28(5):318–319. doi: 10.1111/j.1399-0039.1986.tb00502.x. [DOI] [PubMed] [Google Scholar]
  16. Kovacs B. W., Carlson D. E., Shahbahrami B., Platt L. D. Prenatal diagnosis of human parvovirus B19 in nonimmune hydrops fetalis by polymerase chain reaction. Am J Obstet Gynecol. 1992 Aug;167(2):461–466. doi: 10.1016/s0002-9378(11)91430-6. [DOI] [PubMed] [Google Scholar]
  17. Kurtzman G. J., Cohen B. J., Field A. M., Oseas R., Blaese R. M., Young N. S. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest. 1989 Oct;84(4):1114–1123. doi: 10.1172/JCI114274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Markenson G. R., Yancey M. K. Parvovirus B19 infections in pregnancy. Semin Perinatol. 1998 Aug;22(4):309–317. doi: 10.1016/s0146-0005(98)80019-0. [DOI] [PubMed] [Google Scholar]
  19. Meyers C., Mane M., Kokorina N., Alam S., Hermonat P. L. Ubiquitous human adeno-associated virus type 2 autonomously replicates in differentiating keratinocytes of a normal skin model. Virology. 2000 Jul 5;272(2):338–346. doi: 10.1006/viro.2000.0385. [DOI] [PubMed] [Google Scholar]
  20. Miller E., Fairley C. K., Cohen B. J., Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol. 1998 Feb;105(2):174–178. doi: 10.1111/j.1471-0528.1998.tb10048.x. [DOI] [PubMed] [Google Scholar]
  21. Pryde P. G., Nugent C. E., Pridjian G., Barr M., Jr, Faix R. G. Spontaneous resolution of nonimmune hydrops fetalis secondary to human parvovirus B19 infection. Obstet Gynecol. 1992 May;79(5 ):859–861. [PubMed] [Google Scholar]
  22. Rodis J. F., Quinn D. L., Gary G. W., Jr, Anderson L. J., Rosengren S., Cartter M. L., Campbell W. A., Vintzileos A. M. Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol. 1990 Oct;163(4 Pt 1):1168–1171. doi: 10.1016/0002-9378(90)90681-v. [DOI] [PubMed] [Google Scholar]
  23. Rotbart H. A. Human parvovirus infections. Annu Rev Med. 1990;41:25–34. doi: 10.1146/annurev.me.41.020190.000325. [DOI] [PubMed] [Google Scholar]
  24. Saal J. G., Steidle M., Einsele H., Müller C. A., Fritz P., Zacher J. Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatol Int. 1992;12(4):147–151. doi: 10.1007/BF00274934. [DOI] [PubMed] [Google Scholar]
  25. Schwarz T. F., Jäger G., Gilch S. Comparison of seven commercial tests for the detection of parvovirus B19-specific IgM. Zentralbl Bakteriol. 1997 Apr;285(4):525–530. doi: 10.1016/s0934-8840(97)80114-4. [DOI] [PubMed] [Google Scholar]
  26. Sloots T., Devine P. L. Evaluation of four commercial enzyme immunoassays for detection of immunoglobulin M antibodies to human parvovirus B19. Eur J Clin Microbiol Infect Dis. 1996 Sep;15(9):758–761. doi: 10.1007/BF01691968. [DOI] [PubMed] [Google Scholar]
  27. Takahashi Y., Murai C., Shibata S., Munakata Y., Ishii T., Ishii K., Saitoh T., Sawai T., Sugamura K., Sasaki T. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8227–8232. doi: 10.1073/pnas.95.14.8227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Török T. J., Wang Q. Y., Gary G. W., Jr, Yang C. F., Finch T. M., Anderson L. J. Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique. Clin Infect Dis. 1992 Jan;14(1):149–155. doi: 10.1093/clinids/14.1.149. [DOI] [PubMed] [Google Scholar]
  29. Van Elsacker-Niele A. M., Salimans M. M., Weiland H. T., Vermey-Keers C., Anderson M. J., Versteeg J. Fetal pathology in human parvovirus B19 infection. Br J Obstet Gynaecol. 1989 Jul;96(7):768–775. doi: 10.1111/j.1471-0528.1989.tb03314.x. [DOI] [PubMed] [Google Scholar]
  30. Weigel-Kelley K. A., Yoder M. C., Srivastava A. Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells. J Virol. 2001 May;75(9):4110–4116. doi: 10.1128/JVI.75.9.4110-4116.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Woolf A. D., Campion G. V., Chishick A., Wise S., Cohen B. J., Klouda P. T., Caul O., Dieppe P. A. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med. 1989 May;149(5):1153–1156. [PubMed] [Google Scholar]
  32. Yamakawa Y., Oka H., Hori S., Arai T., Izumi R. Detection of human parvovirus B19 DNA by nested polymerase chain reaction. Obstet Gynecol. 1995 Jul;86(1):126–129. doi: 10.1016/0029-7844(95)00092-6. [DOI] [PubMed] [Google Scholar]
  33. Young N. S., Mortimer P. P., Moore J. G., Humphries R. K. Characterization of a virus that causes transient aplastic crisis. J Clin Invest. 1984 Jan;73(1):224–230. doi: 10.1172/JCI111195. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES